-
Something wrong with this record ?
New clinical scoring system for prognosis of early recurrence of colorectal liver metastases after surgical treatment
S. Alan, L. Vaclav, P. Martin, T. Vladislav, T. Ondrej, S. Tomas, K. Stanislav, L. Holubec
Language English Country Greece
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NS10230
MZ0
CEP Register
PubMed
21937396
DOI
10.5754/hge10045
Knihovny.cz E-resources
- MeSH
- Adult MeSH
- Carcinoembryonic Antigen genetics MeSH
- Colorectal Neoplasms pathology MeSH
- Middle Aged MeSH
- Humans MeSH
- Matrix Metalloproteinase 2 genetics MeSH
- Matrix Metalloproteinase 9 genetics MeSH
- RNA, Messenger analysis MeSH
- Liver Neoplasms metabolism mortality secondary surgery MeSH
- Prognosis MeSH
- Recurrence MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Tissue Inhibitor of Metalloproteinase-1 genetics MeSH
- Tissue Inhibitor of Metalloproteinase-2 genetics MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND/AIMS: To determine the relationship between the mRNA expression of MMP-2, MMP-9, TIMP-1, TIMP-2 and CEA in tumour tissue and preoperative serum levels of these tumour markers in patients with colorectal liver metastases (CLM). Additionally, to establish a new scoring system based upon these results in combination with the volume of the metastatic process to identify patients with a high risk of early recurrence of CLM. METHODOLOGY: The correlation between the mRNA expression of CEA, TIMP-1, TIMP-2, MMP-2 and MMP-9 in tissue samples and preoperative serum levels of the named tumour markers was performed on 27 patients. The scoring system was proposed as a combination of all the independent parameters (mRNA expression of TIMP-1, MMP-9 and CEA in tumour tissue samples and preoperative serum levels of CEA and TIMP-1) in combination with the volume of the metastatic process. The evaluation was conducted in relation to the disease free interval (DFI). RESULTS: We observed a statistically significant relationship between the volume of liver metastases and DFI (p<0.0337). The scoring system divided the patients into groups with a tendency of early recurrence (p<0.0126). CONCLUSIONS: The high stages in our scoring systems augment the risk of recurrence. The proposed scoring system was shown to be an efficient instrument helpful in complex surgical and oncological access to patients after radical surgical treatment of CLM.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12022299
- 003
- CZ-PrNML
- 005
- 20170407134442.0
- 007
- ta
- 008
- 120806s2011 gr f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.5754/hge10045 $2 doi
- 035 __
- $a (PubMed)21937396
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gr
- 100 1_
- $a Sutnar, Alan $7 xx0081862 $u Department of Surgery, Charles University, Prague, Czech Republic.
- 245 10
- $a New clinical scoring system for prognosis of early recurrence of colorectal liver metastases after surgical treatment / $c S. Alan, L. Vaclav, P. Martin, T. Vladislav, T. Ondrej, S. Tomas, K. Stanislav, L. Holubec
- 520 9_
- $a BACKGROUND/AIMS: To determine the relationship between the mRNA expression of MMP-2, MMP-9, TIMP-1, TIMP-2 and CEA in tumour tissue and preoperative serum levels of these tumour markers in patients with colorectal liver metastases (CLM). Additionally, to establish a new scoring system based upon these results in combination with the volume of the metastatic process to identify patients with a high risk of early recurrence of CLM. METHODOLOGY: The correlation between the mRNA expression of CEA, TIMP-1, TIMP-2, MMP-2 and MMP-9 in tissue samples and preoperative serum levels of the named tumour markers was performed on 27 patients. The scoring system was proposed as a combination of all the independent parameters (mRNA expression of TIMP-1, MMP-9 and CEA in tumour tissue samples and preoperative serum levels of CEA and TIMP-1) in combination with the volume of the metastatic process. The evaluation was conducted in relation to the disease free interval (DFI). RESULTS: We observed a statistically significant relationship between the volume of liver metastases and DFI (p<0.0337). The scoring system divided the patients into groups with a tendency of early recurrence (p<0.0126). CONCLUSIONS: The high stages in our scoring systems augment the risk of recurrence. The proposed scoring system was shown to be an efficient instrument helpful in complex surgical and oncological access to patients after radical surgical treatment of CLM.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a karcinoembryonální antigen $x genetika $7 D002272
- 650 _2
- $a kolorektální nádory $x patologie $7 D015179
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nádory jater $x metabolismus $x mortalita $x sekundární $x chirurgie $7 D008113
- 650 _2
- $a matrixová metaloproteinasa 2 $x genetika $7 D020778
- 650 _2
- $a matrixová metaloproteinasa 9 $x genetika $7 D020780
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a messenger RNA $x analýza $7 D012333
- 650 _2
- $a recidiva $7 D012008
- 650 _2
- $a tkáňový inhibitor metaloproteinasy 1 $x genetika $7 D019715
- 650 _2
- $a tkáňový inhibitor metaloproteinasy 2 $x genetika $7 D019716
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Liška, Václav, $d 1978- $7 xx0073943
- 700 1_
- $a Pešta, Martin, $d 1976- $7 xx0073915
- 700 1_
- $a Třeška, Vladislav, $d 1957- $7 jn20000402436
- 700 1_
- $a Topolčan, Ondřej, $d 1943- $7 jn20000402383
- 700 1_
- $a Skalický, Tomáš, $d 1965- $7 xx0017169
- 700 1_
- $a Kormunda, Stanislav $7 xx0103970
- 700 1_
- $a Holubec, Luboš, $d 1941- $7 skuk0003095
- 773 0_
- $w MED00002025 $t Hepato-gastroenterology $x 0172-6390 $g Roč. 58, č. 109 (2011), s. 1286-1290
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21937396 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120806 $b ABA008
- 991 __
- $a 20170407134736 $b ABA008
- 999 __
- $a ok $b bmc $g 944212 $s 779596
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 58 $c 109 $d 1286-1290 $i 0172-6390 $m Hepato-gastroenterology $n Hepatogastroenterology $x MED00002025
- GRA __
- $a NS10230 $p MZ0
- LZP __
- $b NLK111 $a Pubmed-20120806/12/01